Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04582279 · ClinicalTrials.gov registry record · NA
Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients
A NA study of Post-Lung Transplantation Bronchiectasis, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT04582279 is a NA study of Post-Lung Transplantation Bronchiectasis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04582279, a NA study of Post-Lung Transplantation Bronchiectasis, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to study a safe and non-invasive way to diagnose lung rejection and infection.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Lung ultrasound
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2020-10-28 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04582279
The ClinicalTrials.gov registry entry for NCT04582279 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-Lung Transplantation Bronchiectasis appearing as the primary indexed condition, and to 1 intervention - of which Lung ultrasound is the first listed.
NCT04582279 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04582279 about?
NCT04582279 is a clinical study titled "Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients". This study is being done to study a safe and non-invasive way to diagnose lung rejection and infection.
What is the current status of trial NCT04582279?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2020-10-28. Estimated completion is 2026-12-30.
What conditions does trial NCT04582279 study?
This clinical trial studies the following conditions: Post-Lung Transplantation Bronchiectasis.
What interventions are being tested in trial NCT04582279?
The interventions under investigation include: Lung ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04582279?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04582279 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Lung Transplantation Bronchiectasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.